BECLOMETHASONE DIPROPIONATE | N020911 | TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. CIPLA LTD. et al 6 patentsANDA 211434beclomethasone dipropionate | D.N.J. | 2020-08-07 | Terminated 2023-06-29 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Aurolife Pharma LLC FDA-2018-P-3412 Aurolife Pharma LLC, a subsidiary of Aurobindo Pharma USA, submitted this citizen petition on September 6, 2018, requesting that the FDA determine whether Teva Branded Pharmaceutical Products R and D Inc's QVAR 40 and QVAR 80 (beclomethasone dipropionate HFA inhalation aerosol) under NDA 020911 was | 505(q) | 2018-09-10 | Withdrawn | Aurolife Pharma LLC |
Source: Regulations.gov. FDA citizen petitions matched by application number.